Coverage
-
April 27, 2021
Pharmaceutical manufacturer Indivior has finalized an agreement to pay a total of $300 million to all 50 states to settle allegations it falsely and aggressively marketed the opioid-based drug Suboxone, an alleged scheme that led to the misuse of Medicaid funds, according to a settlement released by the California Attorney General's office Tuesday.
1 other articles on this case.
View all »